Evidence map›Paper›PMID 36014337›Full record

ArticleMolecules (Basel, Switzerland)2022

Comprehensive Evaluation of the Quality of

Yadan Wang, Zhong Dai, Jiangong Yan, Xianfu Wu, Shuangcheng Ma

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Quality Evaluation ofACS omega · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Yadan WangNational Institutes for Food and Drug Control, Beijing 102629, China.ORCID 0000-0002-5753-9571
Zhong DaiNational Institutes for Food and Drug Control, Beijing 102629, China.
Jiangong YanTraditional Chinese Medicine Processing Technology Innovation Center of Hebei Province, College of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang 050200, China.
Xianfu WuNational Institutes for Food and Drug Control, Beijing 102629, China.ORCID 0000-0001-7675-0543
Shuangcheng MaNational Institutes for Food and Drug Control, Beijing 102629, China.
National Institutes for Food and Drug Control · CNChinese Academy of Medical Sciences & Peking Union Medical College · CNHebei University of Chinese Medicine · CN

Funding

State Key Laboratory of Bioactive Substance and Function of Natural Medicines (Open Fund Project) GTZK202201
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Drugs, Chinese HerbalTripterygiumBiological AssayChromatography, High Pressure LiquidGlycosidesTabletsTandem Mass SpectrometryDrugs, Chinese HerbalGlycosidesTabletsanti-inflammatory activitycelastrolcytotoxicitydemethylzelaysteralquality consistencyRRLC–ESI–MS/MSTriptergium glycosides tablets (TGTs)triptolidetriptoquinone B

Identifiers

PMID36014337
PMCPMC9416487
OpenAlexW4291017281

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.